PL372248A1 - Sposoby i kompozycje do leczenia, profilaktyki lub opóźniania wystąpienia nowotworu - Google Patents
Sposoby i kompozycje do leczenia, profilaktyki lub opóźniania wystąpienia nowotworuInfo
- Publication number
- PL372248A1 PL372248A1 PL03372248A PL37224803A PL372248A1 PL 372248 A1 PL372248 A1 PL 372248A1 PL 03372248 A PL03372248 A PL 03372248A PL 37224803 A PL37224803 A PL 37224803A PL 372248 A1 PL372248 A1 PL 372248A1
- Authority
- PL
- Poland
- Prior art keywords
- conpositions
- neoplasm
- treating
- preventing
- methods
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 208000035269 cancer or benign tumor Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37589002P | 2002-04-26 | 2002-04-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL372248A1 true PL372248A1 (pl) | 2005-07-11 |
Family
ID=29270715
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL03372248A PL372248A1 (pl) | 2002-04-26 | 2003-04-25 | Sposoby i kompozycje do leczenia, profilaktyki lub opóźniania wystąpienia nowotworu |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20030212088A1 (pl) |
| EP (1) | EP1501547A1 (pl) |
| JP (1) | JP2005524694A (pl) |
| CN (1) | CN1649627A (pl) |
| AU (1) | AU2003234217A1 (pl) |
| BR (1) | BR0309504A (pl) |
| CA (1) | CA2483557A1 (pl) |
| IL (1) | IL164550A0 (pl) |
| MX (1) | MXPA04010566A (pl) |
| NZ (1) | NZ536017A (pl) |
| PL (1) | PL372248A1 (pl) |
| WO (1) | WO2003090785A1 (pl) |
| ZA (1) | ZA200408455B (pl) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008091465A2 (en) * | 2006-12-21 | 2008-07-31 | Wayne State University | Peg and targeting ligands on nanoparticle surface |
| ES2632348T3 (es) * | 2010-04-28 | 2017-09-12 | University Of Southern California | Déficit de receptores de la hormona del crecimiento como causa de una reducción significativa de la señalización pro-envejecimiento, del cáncer y de la diabetes |
| WO2018102670A2 (en) * | 2016-12-02 | 2018-06-07 | Ohio University | Method of treating cancer and method of sensitizing cancer cells to the action of chemotherapeutic agents via growth hormone receptor antagonists or knock down |
| WO2019211842A1 (en) * | 2018-04-30 | 2019-11-07 | Opko Biologics Ltd. | Long-acting human growth hormone-antagonists and methods of producing the same |
| GB201903546D0 (en) * | 2019-03-15 | 2019-05-01 | Ldn Pharma Ltd | Cancer treatment |
| CA3141128A1 (en) * | 2019-06-17 | 2020-12-24 | Molecular Technologies Laboratories Llc | Therapeutic pegylated growth hormone antagonists |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4179337A (en) * | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
| JPS6019790A (ja) * | 1983-07-14 | 1985-01-31 | Yakult Honsha Co Ltd | 新規なカンプトテシン誘導体 |
-
2003
- 2003-04-25 CN CNA038092581A patent/CN1649627A/zh active Pending
- 2003-04-25 BR BR0309504-5A patent/BR0309504A/pt not_active IP Right Cessation
- 2003-04-25 AU AU2003234217A patent/AU2003234217A1/en not_active Abandoned
- 2003-04-25 MX MXPA04010566A patent/MXPA04010566A/es not_active Application Discontinuation
- 2003-04-25 WO PCT/US2003/012783 patent/WO2003090785A1/en not_active Ceased
- 2003-04-25 JP JP2003587414A patent/JP2005524694A/ja active Pending
- 2003-04-25 EP EP03728527A patent/EP1501547A1/en not_active Withdrawn
- 2003-04-25 CA CA002483557A patent/CA2483557A1/en not_active Abandoned
- 2003-04-25 PL PL03372248A patent/PL372248A1/pl not_active Application Discontinuation
- 2003-04-25 US US10/423,761 patent/US20030212088A1/en not_active Abandoned
- 2003-04-25 NZ NZ536017A patent/NZ536017A/en unknown
-
2004
- 2004-10-13 IL IL16455004A patent/IL164550A0/xx unknown
- 2004-10-19 ZA ZA200408455A patent/ZA200408455B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA04010566A (es) | 2005-07-01 |
| JP2005524694A (ja) | 2005-08-18 |
| US20030212088A1 (en) | 2003-11-13 |
| AU2003234217A1 (en) | 2003-11-10 |
| CA2483557A1 (en) | 2003-11-06 |
| IL164550A0 (en) | 2005-12-18 |
| ZA200408455B (en) | 2005-08-31 |
| WO2003090785A1 (en) | 2003-11-06 |
| NZ536017A (en) | 2006-08-31 |
| CN1649627A (zh) | 2005-08-03 |
| EP1501547A1 (en) | 2005-02-02 |
| BR0309504A (pt) | 2005-02-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL383616A1 (pl) | Środki wiążące inhibitujące miostatynę | |
| IL164219A0 (en) | Method for treating and preventing hyparathyroidism | |
| AU2003291684A8 (en) | Financial account transferapparatus and method | |
| AU2003202196A1 (en) | Devices and methods for heart valve treatment | |
| EP1575513A4 (en) | COMPOSITIONS AND METHODS FOR TREATING RAGE-ASSOCIATED DISEASES | |
| AU2003201868A1 (en) | Aqueous agent for treating substrate, method for treating substrate and treated substrate | |
| EP1494713A4 (en) | PROCESS FOR TREATING TWEAK-RELATED CONDITIONS | |
| AU2002361861A8 (en) | Selective 11beta-hsd inhibitors and methods for use thereof | |
| AU2003291342A1 (en) | Benzotriazoles and methods of prophylaxis or treatment of metabolic-related disorders thereof | |
| EP1482985A4 (en) | TECHNETIUM-DIPYRIDINE COMPLEXES AND METHODS OF USE THEREOF | |
| EP1567198A4 (en) | MATERIALS AND METHOD FOR THE TREATMENT OF EYE DISEASES | |
| GB0612386D0 (en) | Device for preventing and treating myopia | |
| AUPS236902A0 (en) | Composition and method for treating hypertension | |
| AP2147A (en) | A composition for treating aids and associated conditions. | |
| AU2003211009A8 (en) | Compositions and methods for treating pain using cyclooxygenase-1 inhibitors | |
| AU2002232400A1 (en) | Reversed amidines and methods of using for treating, preventing, or inhibiting leishmaniasis | |
| WO2006060787A3 (en) | Delaying or preventing onset of multiple sclerosis | |
| PL372248A1 (pl) | Sposoby i kompozycje do leczenia, profilaktyki lub opóźniania wystąpienia nowotworu | |
| EP1559445A4 (en) | CYTOKIN CONTROL DEVICE, TREATMENT DEVICE AND TREATMENT METHOD | |
| AU2003256526A8 (en) | Arrangements and methods for treating a subject | |
| PL373593A1 (pl) | Zawierająca androgeny kompozycja farmaceutyczna isposób leczenia depresji | |
| AU2003259202A8 (en) | Compositions and methods for treating and preventing infection | |
| IL148452A0 (en) | Method and device for prevention of gimbal-locking | |
| AU2003300781A8 (en) | Methods for treating and preventing sepsis using modified c1 inhibitor or fragments thereof | |
| AU2003299560A1 (en) | Compositions and methods for treating or preventing hearing impairment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |